What this study adds
peripheral retinal ischaemia
DIABETIC MACULAR OEDEMA

This study tests demonstrated that aflibercept with TPRP to areas of peripheral retinal ischaemia in naive and previously treated eyes does not reduce the injection burden for the treatment of diabetic macular oedema.In contrast to the pervious TPRP studies with ranibizumab, this study did not have a loading phase of aflibercept and the treat and extend regimen increased using a 4-week extension interval.This increased the potential to find a difference between the number of injections between the two groups but this was not found.